NCT02153151View on ClinicalTrials.gov

Measuring Biomarker Response to AMP-514 in Blood Samples From Patients With Solid Tumors Undergoing Radiotherapy

CompletedOBSERVATIONAL
Enrollment

21

Participants

Timeline

Start Date

November 11, 2013

Primary Completion Date

February 23, 2016

Study Completion Date

July 14, 2016

Conditions
Unspecified Adult Solid Tumor, Protocol Specific
Interventions
OTHER

Cytology specimen

Correlative studies

OTHER

Laboratory biomarker analysis

Correlative studies

Trial Locations (1)

19107

Thomas Jefferson University, Philadelphia

Sponsors

Collaborators (1)

MedImmune LLC
All Listed Sponsors
collaborator

MedImmune LLC

INDUSTRY

lead

Sidney Kimmel Cancer Center at Thomas Jefferson University

OTHER